We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The noninvasive technology aims to improve melanoma screening outcomes (Photo courtesy of 123RF)

Molecular Imaging to Reduce Need for Melanoma Biopsies

A noninvasive fluorescent imaging technology can detect melanoma without biopsy. More...
27 Feb 2026
Image: Senior author Christopher Hourigan (left) and first author Rasha Al-Ali of Virginia Tech’s Fralin Biomedical Research Institute found that a highly sensitive DNA-based test may help doctors predict which patients with AML are most likely to relapse (Photo courtesy of Lena Ayuk/Virginia Tech)

Ultra-Sensitive DNA Test Identifies Relapse Risk in Aggressive Leukemia

Highly sensitive DNA sequencing can identify minimal disease signals that predict post-transplant relapse risk. More...
27 Feb 2026
Image: The new findings may help inform therapeutic strategies and support biomarker development for Alzheimer\'s Disease (Photo courtesy of 123RF)

Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease

Researchers have identified a a protective neuronal protein that appears reduced in individuals with Alzheimer’s disease. More...
27 Feb 2026
Image: Distinct blood-based metabolic patterns can differentiate gallbladder cancer cases with and without gallstones (Photo courtesy of 123RF)

Blood Test Could Help Detect Gallbladder Cancer Earlier

Blood metabolic signatures may enable earlier detection of gallbladder cancer. More...
27 Feb 2026
Image: Senior author Christopher Hourigan (left) and first author Rasha Al-Ali of Virginia Tech’s Fralin Biomedical Research Institute found that a highly sensitive DNA-based test may help doctors predict which patients with AML are most likely to relapse (Photo courtesy of Lena Ayuk/Virginia Tech)

Ultra-Sensitive DNA Test Identifies Relapse Risk in Aggressive Leukemia

Highly sensitive DNA sequencing can identify minimal disease signals that predict post-transplant relapse risk. More...
27 Feb 2026
Image: The new findings may help inform therapeutic strategies and support biomarker development for Alzheimer\'s Disease (Photo courtesy of 123RF)

Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Detection and Therapy

Researchers have identified a a protective neuronal protein that appears reduced in individuals with Alzheimer’s disease. More...
27 Feb 2026
Image: The noninvasive technology aims to improve melanoma screening outcomes (Photo courtesy of 123RF)

Molecular Imaging to Reduce Need for Melanoma Biopsies

A noninvasive fluorescent imaging technology can detect melanoma without biopsy. More...
27 Feb 2026
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Alcohol Testing Device
Dräger Alcotest 7000